CTi Biopharma Corp (NASDAQ:CTIC)

1.82
Delayed Data
As of Apr 17
 -0.09 / -4.71%
Today’s Change
1.77
Today|||52-Week Range
3.36
-22.88%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +229.67% increase from the last price of 1.82.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$2.8M
Reporting Date
Apr 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 28.70%
 
 
 
 
 
 
Growthannually 13.23%
 
 
 
 
 
 

Sales

Growthquarterly -84.05%
 
 
 
 
 
 
Growthannually -27.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account